Filed pursuant to Rule 433

Registration Statement No. 333-187156

April 3, 2013

 

Sanofi

Final Term Sheet

 

US$1,500,000,000 1.250% Notes Due 2018

 

Issuer

 

Sanofi

 

 

 

Format

 

SEC-registered global notes

 

 

 

Title

 

1.250% Notes due 2018

 

 

 

Total initial principal amount

 

US$1,500,000,000

 

 

 

Issue price

 

99.561%

 

 

 

Pricing date

 

April 3, 2013

 

 

 

Expected settlement date

 

April 10, 2013, which will be the fifth business day following the initial date of trading of the notes (such settlement cycle being referred to as “T+5”). Under applicable rules and regulations, trades in the secondary market generally are required to settle in three business days, unless the parties to any such trade expressly agree otherwise. Accordingly, by virtue of the fact that the initial delivery of the notes will not be made on a T+3 basis, investors who wish to trade the notes before a final settlement will be required to specify an alternative settlement cycle at the time of any such trade to prevent a failed settlement.

 

 

 

Maturity date

 

April 10, 2018, unless earlier redeemed

 

 

 

Day count

 

30/360

 

 

 

Day count convention

 

Following unadjusted

 

 

 

Optional redemption

 

Make-whole call at Treasury Rate plus 10 bps

 

 

 

Tax redemption

 

Applicable

 

 

 

Ranking

 

Unsecured and unsubordinated

 

 

 

Interest rate

 

1.250% per annum

 

 

 

Benchmark Treasury

 

0.750% UST due March 31, 2018

 



 

Benchmark Treasury price

 

100-4+

 

 

 

Benchmark Treasury yield

 

0.721%

 

 

 

Spread to Benchmark Treasury

 

62 bps

 

 

 

Yield to maturity

 

1.341%

 

 

 

Date interest starts accruing

 

April 10, 2013

 

 

 

Interest payment dates

 

Each April 10 and October 10

 

 

 

First interest payment date

 

October 10, 2013

 

 

 

Regular record dates for Interest

 

Each March 25 and September 25

 

 

 

Trustee

 

Deutsche Bank Trust Company Americas

 

 

 

Listing

 

None

 

 

 

Denominations

 

US$2,000 and increments of US$1,000 above that amount

 

 

 

Expected ratings of the Notes

 

Moody’s A1/Stable

 

 

Standard & Poor’s AA-/Stable

 

 

 

 

 

Note: A security rating is not a recommendation to buy, sell or hold securities. Ratings are subject to revision or withdrawal at any time by the assigning rating organization. Each rating should be evaluated independently of any other rating.

 

 

 

CUSIP / ISIN

 

801060 AB0 / US801060AB05

 

 

 

Joint Book-Running Managers

 

Barclays Capital Inc.

 

 

Deutsche Bank Securities Inc.

 

 

J.P. Morgan Securities LLC

 

 

Merrill Lynch, Pierce, Fenner & Smith

 

 

Incorporated

 

 

 

Co-Managers

 

Citigroup Global Markets Inc.

 

 

Credit Agricole Securities (USA) Inc.

 

 

HSBC Securities (USA) Inc.

 

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates.  Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering.  You may obtain these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, copies may be obtained from Barclays Capital Inc., toll-free at 1-888-603-5847; Deutsche Bank Securities Inc., toll-free at 1-800-503-4611; J.P. Morgan Securities LLC, collect at 1-212-834-4533; or Merrill Lynch, Pierce, Fenner & Smith Incorporated, toll free at 1-800-294-1322.